Journal
FUTURE ONCOLOGY
Volume 18, Issue 2, Pages 149-161Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/fon-2021-0883
Keywords
chemotherapy resistance; EGFR; GALNT14; glycosylation; protein stability
Categories
Ask authors/readers for more resources
The study revealed that upregulation of GALNT14 in ovarian cancer is associated with chemoresistance. Inhibiting GALNT14 suppressed apoptosis and ferroptosis of ovarian cancer cells, and downregulating GALNT14 activity on the mTOR pathway through modifying O-glycosylation of EGFR. Finally, a synergistic effect promoting cell death was observed with a combination of an mTOR inhibitor and cisplatin.
Background: Chemoresistance usually occurs in ovarian cancer. We aimed to explore the mechanisms of chemoresistance. Methods: Western blotting assay was used to detect the expression of GALNT14. Further cell function experiments were performed to investigate the effect of GALNT14 in ovarian cancer. Results: GALNT14 is significantly upregulated in ovarian cancer. Downregulation of GALNT14 significantly inhibits both apoptosis and ferroptosis of ovarian cancer cells. A further mechanism assay illustrated that downregulation of GALNT14 suppresses the activity of the mTOR pathway through modifying O-glycosylation of EGFR. Finally, an additive effect promoting cell death occurs with a combination of an mTOR inhibitor and cisplatin. Conclusion: Our study might provide a promising method to overcome cisplatin resistance for patients with ovarian cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available